论文信息 - Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059. - 字舞流文

Phase II trial of dasatinib in triple-negative breast cancer: results of study CA180059.

N. Ibrahim | J. Sparano | R. Finn | L. Goldstein | C. Bengala | O. Sy | H. Roché | L. Strauss | J. Fairchild